MiR-19b-3p Serves as a Potential Diagnostic Biomarker for Parkinson's Disease
Background:
Hundreds of miRNAs have been reported to be dysregulated in Parkinson's disease (PD), providing valuable assistance in improving its diagnosis. The purpose of this study was to analyze the expression and diagnostic value of miR-19b-3p in PD patients, as well as its relationship with inflammatory factors.
Methods:
We recruited 50 PD patients and 50 healthy age- and gender-matched controls and collected demographic data and biochemical parameters from both groups. RT-qPCR was used to detect miR-19b-3p levels in serum. ELISA was used to detect serum levels of TNF-α and IL-1β. Receiver operating characteristic (ROC) curves were constructed to evaluate the diagnostic value of miR-19b-3p in PD patients.
Results:
Serum miR-19b-3p expression was downregulated in PD patients compared with healthy controls. A negative correlation was found between miR-19b-3p levels and the MDS-UPDRS score in PD patients (r = -0.686, p < 0.01). In ROC curve analysis, the area under the curve of miR-19b-3p for prediction of PD was 0.779. In PD patients, serum miR-19b-3p levels were negatively correlated with serum IL-1β (r = -0.556, p < 0.01) and TNF-α levels (r = -0.592, p < 0.01).
Conclusions:
Serum miR-19b-3p might serve as a diagnostic and predictive biomarker for PD. The association detected between miR-19b-3p and two common markers of inflammation (IL-1β and TNF-α) may suggest a role for miR-19b-3p in PD-associated neuroinflammation.
Insights
Serum miR-19b-3p is downregulated in Parkinson's disease (PD) patients and may serve as a diagnostic biomarker. This microRNA is linked to inflammation markers, suggesting a role in PD pathogenesis.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- MicroRNAs (miRNAs) are increasingly recognized as dysregulated in Parkinson's disease (PD), offering potential diagnostic markers.
- Investigating specific miRNAs like miR-19b-3p is crucial for understanding PD pathology and improving diagnosis.
Purpose of the Study:
- To analyze the expression levels of miR-19b-3p in Parkinson's disease (PD) patients.
- To evaluate the diagnostic value of serum miR-19b-3p for PD.
- To explore the relationship between miR-19b-3p and inflammatory factors in PD.
Main Methods:
- Serum samples were collected from 50 PD patients and 50 healthy controls.
- Real-time quantitative PCR (RT-qPCR) was used to measure miR-19b-3p levels.
- Enzyme-linked immunosorbent assay (ELISA) quantified TNF-α and IL-1β. Receiver operating characteristic (ROC) curves assessed diagnostic accuracy.
Main Results:
- Serum miR-19b-3p was significantly downregulated in PD patients compared to controls.
- miR-19b-3p levels negatively correlated with MDS-UPDRS scores (r = -0.686, p < 0.01).
- ROC analysis showed an area under the curve of 0.779 for PD prediction. miR-19b-3p negatively correlated with IL-1β (r = -0.556, p < 0.01) and TNF-α (r = -0.592, p < 0.01).
Conclusions:
- Serum miR-19b-3p demonstrates potential as a diagnostic and predictive biomarker for Parkinson's disease.
- The inverse correlation with IL-1β and TNF-α suggests miR-19b-3p may play a role in PD-associated neuroinflammation.
More Related Videos
Related Concept Videos
01:37Neural Regulation
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...